Biofarm S.A.

BIO

ROBIOFACNOR9

Pharmaceuticals

End-of-day quote Bucharest S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.816 ^RON	-0.73%		-1.69%	-0.97%

Feb. 28	Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Tranche Update on BioFarm SA's Equity Buyback Plan announced on April 18, 2014.

September 17, 2014 at 11:49 am EDT

From April 18, 2014 to September 15, 2014, the company has repurchased 109,486,149 shares, representing 10% for RON 33.4 million. With this, the company has completed the repurchase of 109,486,149 shares, representing 10% for RON 33.4 million under the buyback announced on April 18, 2014.

Latest news about Biofarm S.A.

Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 14	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-10	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-13	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-14	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-12	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-14	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-11-12	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-13	CI
Biofarm S.A. Announces Dividend for 2019, Payable on September 3, 2020	20-08-09	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-14	CI
Biofarm Reports Earnings Results for the First Quarter of 2016	16-05-17	CI
S.C. Biofarm S. A. Reports Sales Results for the First Quarter of 2016	16-05-11	CI
Biofarm Reports Earnings Results for the Year 2015	16-02-17	CI
Biofarm Reports Earnings Results for the First Quarter of 2015	15-05-15	CI
Biofarm Announces Earnings Results for the First Nine Months of 2014	14-11-17	CI
Tranche Update on BioFarm SA's Equity Buyback Plan announced on April 18, 2014.	14-09-17	CI
BioFarm SA's Equity Buyback announced on April 18, 2014, has closed with 109,486,149 shares, representing 10% for RON 33.4 million.	14-09-15	CI
Biofarm Reports Earnings Results for the First Half of 2014	14-08-18	CI

Chart Biofarm S.A.

Duration

Period

More charts

Company Profile

Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Companyâs product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.

Sector

Pharmaceuticals

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BIOFARM S.A.	-0.97%	173M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+21.18%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-8.41%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.27%	4.81B